A panel of outside experts at the FDA has recommended the expanded use of Vytorin (ezetimibe and simvastatin) from Merck inc....
Merck Inc. announced that the FDA has issued a Complete Response Letter regarding Merck's Supplemental New Drug Applications for Zetia...
Merck has announced that the investigational IMPROVE-IT study met its primary and all secondary composite efficacy endpoints. In IMPROVE-IT, patients...
Merck announced that the New England Journal of Medicine published the results of the IMPROVE-IT trial, an investigational study comparing...
A US Federal judge has ruled in two jointly related patent infringement suits against Mylan that a patent on hypolipaemic...
NICE has published revised draft guidance on Ezetrol (ezetimibe), from Merck Inc, that in essence reverts to the guidance being...